Abstract : Dihydroartemisinin/piperaquine (DHA/PPQ) is increasingly deployed as antimalaria drug in Africa. We report the detection in Mali of Plasmodium falciparum infections carrying plasmepsin 2 duplications (associated with piperaquine resistance) in 7/65 recurrent infections within 2 months after DHA/PPQ treatment. These findings raise concerns about the long-term efficacy of DHA/PPQ treatment in Africa.
https://www.hal.inserm.fr/inserm-02093060
Contributor : Christine Dupuis
<>
Submitted on : Monday, April 8, 2019 - 4:06:33 PM
Last modification on : Thursday, April 11, 2019 - 1:03:09 AM
Long-term archiving on: Tuesday, July 9, 2019 - 5:14:55 PM
File
Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed
until : jamais
Juliana Inoue, Miguel Silva, Bakary Fofana, Kassim Sanogo, Andreas Mårtensson, et al.. Plasmodium falciparum Plasmepsin 2 Duplications, West Africa. Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2018, 24 (8), pp.1591-1593. ⟨10.3201/eid2408.180370⟩. ⟨inserm-02093060⟩
